Apnimed is having sweet dreams of an IPO that could fund the planned commercial launch of an obstructive sleep apnea therapy that is currently awaiting an FDA approval decision.
- Home |
- Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA’s desk
Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA’s desk
- July 12, 2026
Recent Posts
- Oil jumps 5% as Hormuz tanker attacks escalate, US Gulf hurricane shuts in production
- Crescent Energy to acquire Eagle Ford assets from Devon for $4.2 billion
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
